FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role (role) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely methotrexate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Cetuximab 5 mg/mL solution for infusion Plays role False Antineoplastic therapeutic role Inferred relationship Some
Cetuximab 5 mg/mL solution for infusion and/or injection Plays role False Antineoplastic therapeutic role Inferred relationship Some
Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant Plays role False Antineoplastic therapeutic role Inferred relationship Some
Methotrexate 50 mg/mL solution for injection Plays role False Antineoplastic therapeutic role Inferred relationship Some
Interferon beta-1a 60 microgram/mL solution for injection Plays role False Antineoplastic therapeutic role Inferred relationship Some
Vinorelbine (as vinorelbine tartrate) 30 mg oral capsule Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely vinorelbine (as vinorelbine tartrate) 20 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Vinorelbine only product in oral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Vinorelbine-containing product in oral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely everolimus 2 milligram/1 each conventional release orodispersible tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely everolimus 3 milligram/1 each conventional release orodispersible tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Gimeracil 4.35 mg and oteracil (as oteracil potassium) 11.8 mg and tegafur 15 mg oral capsule Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only gimeracil and oteracil and tegafur (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing gimeracil and oteracil and tegafur (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely palbociclib 125 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Gimeracil and oteracil and tegafur only product in oral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Palbociclib 100 mg oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Some
Palbociclib 75 mg oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Some
Gimeracil- and oteracil- and tegafur-containing product in oral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely tipiracil (as tipiracil hydrochloride) 8.19 milligram and trifluridine 20 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release intravesical solution (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only mitomycin in intravesical dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely darolutamide 300 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Gilteritinib (as gilteritinib fumarate) 40 mg oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Some
Enzalutamide 40 mg oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing mitomycin in intravesical dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely glasdegib (as glasdegib maleate) 25 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Glasdegib (as glasdegib maleate) 100 mg oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely cytarabine 100 milligram and daunorubicin 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only cytarabine and daunorubicin (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing cytarabine and daunorubicin in parenteral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing cytarabine and daunorubicin (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only cytarabine and daunorubicin in parenteral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely gimeracil 5.8 milligram and oteracil (as oteracil potassium) 15.8 milligram and tegafur 20 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Selumetinib (as selumetinib hydrogen sulfate) 10 mg oral capsule Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely selumetinib (as selumetinib hydrogen sulfate) 25 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely acalabrutinib 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely pertuzumab 80 milligram/1 milliliter and trastuzumab 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely pertuzumab 60 milligram/1 milliliter and trastuzumab 60 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Pertuzumab and trastuzumab only product in parenteral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing pertuzumab and trastuzumab in parenteral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Pertuzumab and trastuzumab only product Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing pertuzumab and trastuzumab (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely interferon alfa-2b (as ropeginterferon alfa-2b) 500 microgram/1 milliliter conventional release solution for injection (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Nilotinib (as nilotinib hydrochloride) 50 mg oral capsule Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely fluorouracil 5 milligram/1 gram and salicylic acid 100 milligram/1 gram conventional release cutaneous solution (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only fluorouracil and salicylic acid (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely everolimus 1 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely fluorouracil 40 milligram/1 gram conventional release cutaneous cream (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Everolimus 2 mg dispersible oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Some
Bortezomib 2.5 mg/mL solution for injection Plays role False Antineoplastic therapeutic role Inferred relationship Some
Everolimus 3 mg dispersible oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Some
Everolimus 5 mg dispersible oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Some
Chlormethine only product in cutaneous dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing only fluorouracil and salicylic acid in cutaneous dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely lenalidomide 7.5 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Chlormethine (as chlormethine hydrochloride) 160 microgram/g cutaneous gel Plays role False Antineoplastic therapeutic role Inferred relationship Some
Chlormethine-containing product in cutaneous dose form Plays role False Antineoplastic therapeutic role Inferred relationship Some

Start Previous Page 17 of 17

This concept is not in any reference sets

Back to Start